| B |
|
Barriers to Appropriate Anticoagulation with Warfarin in Orthopedic Surgery
|
| Blackburn J, Schumock G, Bauman J, Caprini J, Nutescu E |
| |
|
Behaviour of the Two-Step Coagulation Assay to Identify Antib2-glycoprotein I (ab2GPI)-Lupus Anticoagulant (LA) in Patients with Antiphospholipid Antibodies
|
| Gennari LC, Blanco AN, Alberto MF, Grosso S, Lazzari MA |
| |
|
Benefit of Fondaparinux in Medical Patients: A Subgroup Analysis
|
| Cohen AT, Gallus AG, Davidson BL, Lassen MR, Prins MH, Tomkowski W, Turpie AGG, Egberts JFM, Lensing AWA |
| |
|
Betaine, a Novel Anticoagulant with Combined Nitric Oxide and Tissue Factor Pathway Release Potential. Implications in the Management of Peripheral Vascular Diseases
|
| Iqbal O, Messadek J, Fareed D, Ennamany R, Cunanan J, Florian M, Hoppensteadt D, Fareed J, Smith B, Harrison N, Matthews P |
| |
|
Beta-Thromboglobulin, Platelet Factor 4 and Soluble P-Selectin in Hemodialysis Patients with EPO Therapy
|
| Sta[scaron]ko J, Ivanková J, Peterková M, Funiaková S, Hollý P, Kubisz P |
| |
|
Beyond Endocytosis: LRP Function in Cell Migration, Proliferation and Vascular Permeability
|
| Strickland DK, Lillis AP, Mikhailenko I |
| |
|
Bilateral Ankle Prosthesis in a Severe Von Willebrand Disease Patient under Substitutive Wilfactin Treatment
|
| Polack B, Asencio JG, Gaudin P, Pouzol P, Pernod G, Barro C, Bridey F, Tellier Z, Hilbert L, Mazurier C |
| |
|
Binding of Amyloid to the Fibronectin Type I Domain of tPA And Factor XII Induces Activation of the Fibrinolytic System and the Contact System
|
| Bouma B, Schiks B, Maas C, Hazenberg BPC, Lokhorst HM, de Groot PhG, Gebbink MFBG |
| |
|
Binding of B2GP1 to Various Phospholipid Mixtures Is Calcium Dependent and Is Dramatically Enhanced by Antibodies: Understanding the Anticoagulant Paradox
|
| Amiral J, Vissac AM |
| |
|
Binding Sites for PAI-1 Are Exposed in Fibrin But Not in Fibrinogen
|
| Smolarczyk K, Boncela J, Szymanski J, Cierniewski CS |
| |
|
Biochemical and Pharmacologic Profiling of a Novel Dual Acting Antithrombin Agent with Antiprotease and Antiplatelet Actions
|
| Hoppensteadt D, Haque W, Diakur J, Florian-Kujawski M, Maddineni J, Neville B, Fareed J |
| |
|
Biochemical and Pharmacological Equivalence of Generic Versions of Low Molecular Weight Heparins. A Comparative Study with Innovator Products
|
| Jeske WP, Ma Q, Maddineni J, Hoppensteadt D, Leong W, Walenga JM, Fareed J, Bick RL |
| |
|
Biochemical Predictors of One-Year Total Mortality in Unselected Acute Coronary Syndromes Patients Treated according to Contemporary Guidelines
|
| Flipiak KJ, Grabowski M, Glowczynska R, Karpinski G, Rdzanek A, Szpotanska M, Pierscinska-Jedra M, Rudzki D, Lodzinska J, Opolski G |
| |
|
Biodistribution of a Covalent Antithrombin-Heparin Complex
|
| Chindemi PA, Konecny F, Berry LR, Smith LJ, Klement P, Chan AKC |
| |
|
Biological Properties of a Specific Gaq/11 Inhibitor, YM-254890, on Platelet Functions and Thrombus Formation under High-shear Stress
|
| Toshio U, Tomihisa K, Masatoshi T, Yumiko M, Kazumi H, Tetsu S, Jun T, Wataru U, Keiji M |
| |
|
Bleeding Determinants in Congenital FVII Deficiency
|
| Mariani G |
| |
|
Bleeding Events in Carriers Of Haemophilia A – Dependent on the Factor VIII-Activity or the Age of the Carriers?
|
| Miesbach W, Oldenburg J, Scharrer I |
| |
|
Bleeding Events with and without Thienopyridines in Patients with Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction. The Global Registry of Acute Coronary Events
|
| Stiles MK, Dabbous OH, Fox KAA |
| |
|
Bleeding Events with Lytics and Thienopyridines in Patients with ST-Segment Elevation Myocardial Infarction. The Global Registry of Acute Coronary Events
|
| Agnelli G, Lopez-Sendon J, Dabbous OH, Lopez de Sa E, Gore JM, Brieger D, Van de Werf F, Gurfinkel EP, Fox KAA |
| |
|
Bleeding Prophylaxis in Children with Haemophilia A/B Using Plasma-derived Concentrates Immunate/Immunine – Prospective Survey
|
| Blatny J, Kohlerova S, Komrska V, Pospisilova D, Blazek B, Brauner R, Chroust K, Dusek L |
| |
|
Blockade of Microvascular Endothelial Cell Replication, Migration, Tubule Formation, Matrix Angiogenesis and Retinal Neovascularization by siRNA Targeting the Basic Region-Leucine Zipper Transcription Factor cJun
|
| Zhang G, Fahmy RG, diGirolamo N, Khachigian LM |
| |
|
Blood Borne Tissue Factor: Weak TF Activity In Monocytes and Microparticles But Lack of TF Activity in Collagen/Thrombin Activated Platelets
|
| Breimo ES, Olsen JO, Osterud B |
| |
|
Blood Leukocyte mRNA Expression of CD34 and VEGFR-2 Is Reduced, But Ve-cadherin and CD14 mRNA Expression Is Increased Following Elective Abdominal Aortic Aneurysm Repair
|
| Millar C, Stirling D, Woodward A, Rae M, Ludlam C |
| |
|
Body Weight and Height, Obesity and Factor V Leiden. Risk of Venous Thrombosis in the Mega Study
|
| Pomp ER, Doggen CJM, Rosendaal FR |
| |
|
Bone Marrow-Derived CD34+ Cells, Modified to Express Anticoagulants on Differentiation, Promote Repair to a Pre-Injured State after Endovascular Injury
|
| Chen D, Weber M, McVey JH, Kemball-Cook G, Tuddenham EGD, Lechler RI, Dorling A |
| |
|
Both Haploinsufficiency and Dominant Negative Effect Are Responsible for Hematological Abnormalities of Patients with 
-Related Disease
|
| Pecci A, Canobbio I, Balduini A, Cisterna B, Marseglia C, Noris P, Savoia A, Torti M, Balduini CL |
| |
|
Both, COP I and COP II Coatomers Are Involved in the Anterograde ER to Golgi Transport of B-domain Deleted FVIII
|
| Heinz S, Simpson J, Becker S, Germer M, Behrmann M, Pepperkok R, Seifried E, Tonn T |
| |
|
Brachial Artery Thrombosis in Infants: A Multidisciplinary Algorithm for Limb Salvage
|
| Coombs CJ, Richardson PW, Dowling GJ, Johnstone BR, Monagle P |
| |
|
Brain Natriuretic Peptide in Hemodynamically Stable Acute Pulmonary Embolism
|
| Söhne M, ten Wolde M, Boomsma F, Reitsma JB, Douketis JD, Büller HR |
| |
|
Bridging Anticoagulation With Enoxaparin Is Effective and Safe in Patients with a Mechanical Heart Valve (MHV) Who Require Temporary Interruption of Vitamin K Antagonist (VKA) Therapy
|
| Turpie AGG, Douketis J |
| |
